National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 288459

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

VAERS ID: 288459
VAERS Form:
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 0 - / IM

Administered by: Other      Purchased by: Unknown
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type':

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml fi"rst dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. T


Changed on 12/8/2009

VAERS ID: 288459 Before After
VAERS Form:
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 0 - / IM

Administered by: Other      Purchased by: Unknown Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': (blank) WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml fi"rst first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. T The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.


Changed on 9/14/2017

VAERS ID: 288459 Before After
VAERS Form:(blank) 1
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 0 1 - / IM

Administered by: Other      Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.


Changed on 2/14/2018

VAERS ID: 288459 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 - / IM

Administered by: Other      Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.


Changed on 6/14/2018

VAERS ID: 288459 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 - / IM

Administered by: Other      Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.


Changed on 8/14/2018

VAERS ID: 288459 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 - / IM

Administered by: Other      Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.


Changed on 9/14/2018

VAERS ID: 288459 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 - / IM

Administered by: Other      Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.


Changed on 10/14/2018

VAERS ID: 288459 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:West Virginia
Vaccinated:2007-07-02
Onset:2007-07-02
Submitted:2007-08-17
Entered:2007-08-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 - / IM

Administered by: Other      Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC 'Split Type': WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=288459&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166